Combating Atherosclerosis With LXRα And PPARα Agonists: Is Rational Multitargeted Polypharmacy the Future of Therapeutics
in Complex Diseases? Mol Interv October 2004 4:254-257; doi:10.1124/mi.4.5.5
Combating Atherosclerosis With LXRα And PPARα Agonists: Is Rational Multitargeted Polypharmacy the Future of Therapeutics
in Complex Diseases? Mol Interv October 2004 4:254-257; doi:10.1124/mi.4.5.5